Loading…
Indian consumer goods company known for Parachute coconut oil, Saffola edible oils and personal-care brands.
Indian consumer goods company known for Parachute coconut oil, Saffola edible oils and personal-care brands.
Sells through distributors that reach a very large number of small shops, including in rural India, with Parachute coconut oil the long-standing base. Copra, the dried coconut it presses, is its main raw material, so it adjusts prices and pack sizes as costs move. The Mariwala family is the promoter and largest shareholder.
In one line: India's smaller Unilever for hair/edible oils.
Moat: narrow (brand, distribution). Dominant, long-established brands in coconut oil and edible oils with deep rural/urban distribution.
Headquarters: Mumbai, India · Founded: 1990 · Employees: 1,995
Size Marico (MARICO.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $12.3B, the 93rd largest of 1,058 India companies the cockpit tracks. Shares closed at ₹897.75 on 6 Nov 2026.
Performance Over six months the shares gained 7.9%, against +16.2% for the median peer and 0.0% for the India market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 20.1% over the last twelve months (peer median +6.2%); the operating margin is 16.4% (peer median 13.9%).
Valuation It trades at 51.8× forward earnings against a peer median of 24.4× (most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 28% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +17 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 38.3 points above its cost of capital (11.4% WACC).
Next results Next results expected around 29 Jan 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹147B | ₹136B | ₹108B | ₹95.8B | ₹97.0B |
| Revenue growth | — | +26% | +12% | -1% | — |
| Gross profit | ₹55.2B | ₹44.0B | ₹39.6B | ₹35.8B | ₹32.0B |
| EBITDA | ₹26.4B | ₹22.8B | ₹20.6B | ₹19.6B | ₹17.5B |
| Net income | ₹20.2B | ₹17.6B | ₹16.3B | ₹14.8B | ₹13.0B |
| Free cash flow | n/a | ₹17.5B | ₹12.2B | ₹12.9B | ₹12.4B |
| Capital expenditure | n/a | ₹3.19B | ₹1.61B | ₹1.53B | ₹1.82B |
| Total debt | ₹12.4B | ₹5.57B | ₹5.54B | ₹5.15B | ₹6.04B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Marico MARICO.NS | $12.3B | +8% | +20% | 16% | 51.8× | 28.0% |
| Dabur India DABUR.NS | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% |
| Godrej Consumer Products GODREJCP.NS | $9.19B | -18% | +12% | 18% | 37.0× | 31.7% |
| Emami EMAMILTD.NS | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% |
| Bajaj Consumer Care BAJAJCON.NS | $551M | -24% | +29% | 22% | 19.6× | 14.6% |
| Hindustan Unilever HINDUNILVR.NS | $49.6B | -12% | +6% | 21% | 41.5× | 27.2% |
| AWL Agri Business AWL.NS | $2.30B | -21% | +18% | 2% | 17.6× | 13.4% |
| Patanjali Foods PATANJALI.NS | $4.75B | -11% | +19% | 4% | 27.1× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | MARICO.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +14.0% | +9.8% | 5th highest of 21 |
| 6-month return | +7.9% | +16.2% | 7th lowest of 21 |
| Distance from 52-week high | -0.1% | -10.2% | highest of 21 |
| Revenue growth (TTM) | +20.1% | +6.2% | 5th highest of 21 |
| Operating margin | 16.4% | 13.9% | 8th highest of 21 |
| Forward P/E | 51.8× | 24.4× | most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 28.0% | 4.0% | 3rd most demanding of 20 |
| Growth delivered (Del g) | +11.1% | +5.4% | 7th highest of 20 |
| Hurdle (Req g minus delivered) | +16.9 pp | -2.8 pp | 5th most demanding of 20 |
| ROIC minus cost of capital | +38.3 pp | +5.4 pp | 3rd highest of 20 |
| EV / EBITDA | 43.6× | 15.8× | most expensive of 18 |
| Net debt / EBITDA | -0.7× | 0.2× | 7th least indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Marico MARICO.NS | India | $12.3B | +8% | +20% | 16% | 51.8× | 28.0% | +11.1% |
| Unicharm 8113.T | Japan | $12.1B | +15% | 0% | 12% | 24.5× | -2.0% | +5.4% |
| Puig Brands PUIG.MC | Spain | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% | +11.7% |
| Clorox CLX | United States | $12.1B | +8% | +6% | 14% | 17.4× | 2.7% | -1.8% |
| Shiseido 4911.T | Japan | $9.52B | +20% | +5% | 4% | 32.8× | 17.5% | +1.0% |
| Godrej Consumer Products GODREJCP.NS | India | $9.19B | -18% | +12% | 18% | 37.0× | 31.7% | +6.6% |
| Essity ESSITY-A.ST | Sweden | $19.9B | +17% | -2% | 12% | 15.4× | -3.3% | +2.6% |
| Beiersdorf BEI.DE | Germany | $20.4B | +21% | -2% | 12% | 22.6× | -2.3% | +7.0% |
| Dabur India DABUR.NS | India | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% | +6.6% |
| APR 278470.KS | South Korea | $7.04B | -40% | +119% | 23% | 17.4× | -1.4% | +47.3% |
| Kao 4452.T | Japan | $21.8B | +33% | +6% | 10% | 24.4× | 1.5% | +4.1% |
| e.l.f. Beauty ELF | United States | $6.85B | +91% | +31% | 12% | 35.4× | 27.9% | +38.8% |
| Amorepacific 090430.KS | South Korea | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% | -0.8% |
| Church & Dwight CHD | United States | $25.8B | +17% | +2% | 18% | 27.4× | 6.9% | +4.8% |
| DSM-Firmenich DSFIR.AS | Netherlands | $29.5B | +62% | -45% | 8% | 30.1× | 24.3% | +2.5% |
| Reynolds Consumer Products REYN | United States | $5.08B | +10% | +2% | 14% | 14.6× | -0.2% | +2.7% |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.92B | -28% | +32% | 31% | 15.0× | 4.7% | +41.1% |
| Cupid CUPID.NS | India | $4.83B | +158% | +122% | 34% | n/a | n/a | n/a |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.83B | -23% | +9% | 28% | 32.2× | 30.8% | +4.5% |
| Interparfums IPAR | United States | $4.34B | +43% | +3% | 17% | 29.0× | 10.9% | +22.5% |
| Rohto Pharmaceutical 4527.T | Japan | $3.97B | +17% | +10% | 12% | 16.7× | -2.1% | +13.7% |